Researchers Uncover DNA Self-Damage Strategy Behind Cancer Growth

What if cancer's biggest superpower is secretly its biggest weakness?

Cancer cells grow at breakneck speed-but that relentless pace may come at a cost. A new study published in Science Advances suggests that tumors may repeatedly damage their own DNA while keeping growth-promoting genes running at maximum capacity, potentially creating a new target for future cancer treatments.

Researchers from the Hebrew University of Jerusalem found that powerful DNA control regions called super-enhancers push cancer-related genes into overdrive. While this fuels rapid tumor growth, it also places enormous stress on nearby DNA, causing dangerous double-strand breaks, one of the most severe forms of genetic damage.

Using advanced genome-mapping techniques, the team discovered that these breaks were not random. Instead, they clustered around genes controlled by super-enhancers. Cancer cells repeatedly repaired this damage, allowing them to survive—but each repair carried the risk of introducing new mutations.

Over time, this cycle of DNA breakage and imperfect repair may make tumors genetically unstable, helping them evolve, spread, and even develop resistance to treatment.

“Our findings show that the same machinery cancer relies on for rapid growth may also create DNA break hotspots,” said senior author Prof. Rami Aqeilan. Lead researcher Osama Hidmi added that these stressed DNA regions could become an Achilles’ heel for cancer cells.

Because tumors depend heavily on super-enhancer activity to sustain growth, scientists believe disrupting these regions—or blocking the repair of the resulting DNA damage—could make cancer cells far more vulnerable.

The researchers emphasize that these findings are still at an early stage and do not immediately translate into new therapies. However, they offer fresh insight into why cancer genomes become so unstable and identify a promising direction for future drug development.

If confirmed in further studies, cancer’s constant race to grow could ultimately become the very weakness scientists learn to exploit.

REFERENCE: Osama Hidmi, Diala Shatleh, Sara Oster Flayshman, Jonathan Monin, Rami I. Aqeilan. Superenhancers shape the landscape and repair dynamics of transcription-associated DNA breaks in cancer. Science Advances, 2026; 12 (4) DOI: 10.1126/sciadv.aeb6379